CVA Family Office’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$789K Sell
10,083
-741
-7% -$59.8K 0.07% 152
2026
Q1
$938K Buy
10,824
+307
+3% +$29.4K 0.1% 116
2025
Q4
$1.01M Buy
10,517
+2
+0% +$194 0.12% 104
2025
Q3
$1M Buy
10,515
+91
+0.9% +$8.37K 0.13% 104
2025
Q2
$909K Sell
10,424
-486
-4% -$41.2K 0.13% 106
2025
Q1
$980K Buy
10,910
+704
+7% +$63K 0.15% 100
2024
Q4
$815K Buy
10,206
+2,218
+28% +$192K 0.13% 109
2024
Q3
$719K Sell
7,988
-644
-7% -$54.2K 0.12% 119
2024
Q2
$679K Sell
8,632
-389
-4% -$31.9K 0.12% 114
2024
Q1
$786K Buy
9,021
+6
+0.1% +$512 0.14% 104
2023
Q4
$743K Sell
9,015
-705
-7% -$53.7K 0.14% 102
2023
Q3
$762K Sell
9,720
-233
-2% -$19.5K 0.17% 93
2023
Q2
$877K Buy
9,953
+852
+9% +$73.3K 0.18% 85
2023
Q1
$734K Buy
9,101
+2,731
+43% +$223K 0.16% 96
2022
Q4
$495K Sell
6,370
-2,320
-27% -$188K 0.12% 116
2022
Q3
$702K Buy
8,690
+3,636
+72% +$327K 0.19% 87
2022
Q2
$454K Buy
5,054
+1,175
+30% +$119K 0.12% 103
2022
Q1
$430K Buy
3,879
+1,407
+57% +$149K 0.1% 111
2021
Q4
$256K Buy
2,472
+1,039
+73% +$120K 0.06% 151
2021
Q3
$149K Sell
1,433
-2,950
-67% -$382K 0.11% 99
2021
Q2
$544K Buy
4,383
+1,620
+59% +$203K 0.15% 88
2021
Q1
$326K Buy
2,763
+1,130
+69% +$132K 0.12% 100
2020
Q4
$191K Buy
1,633
+200
+14% +$22K 0.12% 97
2020
Q3
$149K Buy
1,433
+212
+17% +$21.3K 0.11% 99
2020
Q2
$112K Buy
1,221
+608
+99% +$58.3K 0.09% 106
2020
Q1
$55K Buy
+613
New +$65.2K 0.06% 135

Other funds holding MDT

CVA Family Office's MDT Position: Q2 2026 in Review

CVA Family Office reduced its Medtronic (MDT) stake by 6.8% in Q2 2026, selling an estimated $59.8K and leaving 10,083 shares worth $789K. The position accounts for 0.07% of the portfolio, ranked #152.

CVA Family Office first reported a position in MDT in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.01M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • CVA Family Office held 10,083 shares of Medtronic worth $789K as of Q2 2026.
  • CVA Family Office sold 741 Medtronic shares in Q2 2026, an estimated $59.8K.
  • Medtronic made up 0.07% of CVA Family Office's portfolio in Q2 2026, its #152 holding.
  • CVA Family Office first reported a position in Medtronic in Q1 2020 and has held it in 26 quarters since.
  • CVA Family Office's Medtronic position peaked at $1.01M in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.